Refine by
Regenerative Medicine Articles & Analysis
205 news found
“We know the future of regenerative medicine is physician-based AI-enabled workflows said Croom Lawrence, CCO. ...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the availability of its quality Purified Exosomes to support research in drug delivery, regenerative medicine, and various therapeutic applications. Exosomes are extracellular vesicles secreted by human cells that exhibit biofilm characteristics. ...
The HZ-PEG-HZ (1K) product is critical for applications including: l Controlled Drug Delivery Systems: Leveraging its pH-sensitive hydrazone bonds for targeted and controlled release of active pharmaceutical ingredients in specific physiological environments (e.g., tumor microenvironments, endosomes, lysosomes). l Bioconjugation and Crosslinking: Facilitating the creation of stable linkages in ...
Additionally, exosome-loaded protein-based therapy is opening new doors for regenerative medicine, while limb occlusion research is enhancing vascular treatments. ...
This strategic enhancement aims to support and accelerate research in regenerative medicine, drug delivery, and related fields by providing high-quality, stem cell-derived exosomes tailored to diverse scientific needs. ...
These hydrogels are pivotal in medical devices, regenerative medicine, drug delivery systems, 3D cell culture, and wound healing." ...
The precise tissue dissociation guaranteed by this technology preserves cellular integrity, producing high-quality suspensions essential for a variety of applications, including regenerative medicine and drug discovery. Intrigued? Find out more in our first application note in the “Mastering Tissue Dissociation” series. ...
By providing scientists with tools that better mimic the complex biological processes that occur in vivo, these products enable more accurate and reliable results in drug discovery, toxicology studies, and regenerative medicine research. “We are excited to bring these cutting-edge 3D cell culture systems to our customers,” said the business ...
(NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines is one of NASDAQ's top gainers today and the stock is trending on Yahoo Finance, currently trading at $3.8955, up $1.6955 or 77.0682%. ...
In the field of regenerative medicine and tissue engineering, the demand for collagen-based biomaterials is rapidly increasing. ...
This comprehensive range, featuring tailored bio-inks for specific applications, paves the way for revolutionary advancements in regenerative medicine, drug discovery, and beyond. Bio-ink is a material used in the 3D bioprinting industry to create structures that can imitate natural tissues and organs. ...
ByMatexcel
CELLINK, a global leader in bioprinting technologies, is proud to announce a pioneering innovation in the field of regenerative medicine and tissue engineering with the launch of CELLINK Vivoink, the first-ever medical-grade bioink specially designed to support researchers on their clinical translational journey. ...
ByCELLINK
Shaochen Chen, a pioneer and expert in 3D printing and biofabrication, who has published extensively on bioprinting techniques for tissue engineering and regenerative medicine. The Centre of Excellence will provide researchers at UCSD and beyond with increased access to CELLINK bioprinting technologies and support their efforts to develop innovative solutions to ...
ByCELLINK
By delivering precise molecular insights, CD Genomics is contributing to discoveries in fields such as cancer biology, immunology, neurobiology, and regenerative medicine. About CD Genomics CD Genomics is a genomics service provider well-known for providing reliable sequencing and bioinformatics analysis services, covering the delivery of high-quality ...
(IVS) is a leading developer of proprietary human 3D cell/tissue culture models for highly-predictive, multi-parameter phenotypic assays both in pharmacology safety & discovery screening and in personalized and regenerative medicine. IVS’s Functional 3D tissue models recapitulate the physiological properties of human cardiac, smooth and skeletal muscle ...
Ayla Annac, InvivoSciences: InvivoSciences (IVS) is a leading developer of proprietary, award-winning platform technologies that creates human 3D cell/tissue culture models and their automated phenotype analyzers for drug discovery and precision medicine development. IVS’s functional 3D tissue models reconstitute the physiological properties of human cardiac, smooth and ...
While on January 20th 2014, InvivoSciences and BMG LABTECH will be presenting a workshop tutorial at Society for Laboratory Automation and Screening (SLAS) in San Diego, CA These Workshops will highlight applications of pluripotent cells and engineered tissues in drug discovery, including disease model generation as well as personalized and regenerative ...
“We are pleased to receive this prestigious SBIR research grant from the NSF and for the validation of our technology that it represents,” stated Dr. Hyler. She added, “As medicine moves towards personalized care, more precise cell recovery is required for research and pharmaceutical development, especially in the new fields of cell therapeutics and genomics. ...
Advances in cell replacement therapy, for example, are making it possible for scientists to genetically engineer a patient’s own T-cells so they can specifically target antigens expressed only on the surface of tumor cells. Similar innovations in regenerative medicine and stem cell therapy are likewise opening the way for potentially revolutionary ...
To systematically uncover the therapeutic links between secreted proteins and diseases, Juvena has developed a computational platform that mines proteins secreted by regenerative stem cells and screens this rich pool of drug candidates across therapeutic areas to discover and engineer novel biologics. ...